pLKO.1-TRC.mKO2_shGFP Citations (2)

Originally described in: Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
Quintero M, Adamoski D, Reis LMD, Ascencao CFR, Oliveira KRS, Goncalves KA, Dias MM, Carazzolle MF, Dias SMG BMC Cancer. 2017 Nov 7;17(1):727. doi: 10.1186/s12885-017-3726-2. PubMed Journal

---

Articles Citing pLKO.1-TRC.mKO2_shGFP

Articles
Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer. Yu X, Zhou L, Liu W, Liu L, Gao F, Li W, Liu H. Cell Death Dis. 2022 Mar 18;13(3):249. doi: 10.1038/s41419-022-04685-0. PubMed
Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance. Li M, Gao F, Li X, Gan Y, Han S, Yu X, Liu H, Li W. Cell Death Dis. 2022 Dec 19;13(12):1053. doi: 10.1038/s41419-022-05500-6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.